Rectal Omeprazole in Infants With Gastroesophageal Reflux Disease: A Randomized Pilot Trial.

MLA

Bestebreurtje, Petra, et al. “Rectal Omeprazole in Infants With Gastroesophageal Reflux Disease: A Randomized Pilot Trial.” European Journal of Drug Metabolism and Pharmacokinetics, vol. 45, no. 5, Oct. 2020, pp. 635–43. EBSCOhost, https://doi.org/10.1007/s13318-020-00630-8.

APA

Bestebreurtje, P., de Koning, B. A. E., Roeleveld, N., Knibbe, C. A. J., Tibboel, D., van Groen, B., van de Ven, C. P., Plötz, F. B., & de Wildt, S. N. (2020). Rectal Omeprazole in Infants With Gastroesophageal Reflux Disease: A Randomized Pilot Trial. European Journal of Drug Metabolism and Pharmacokinetics, 45(5), 635–643. https://doi.org/10.1007/s13318-020-00630-8

Chicago

Bestebreurtje, Petra, Barbara A E de Koning, Nel Roeleveld, Catherijne A J Knibbe, Dick Tibboel, Bianca van Groen, Cees P van de Ven, Frans B Plötz, and Saskia N de Wildt. 2020. “Rectal Omeprazole in Infants With Gastroesophageal Reflux Disease: A Randomized Pilot Trial.” European Journal of Drug Metabolism and Pharmacokinetics 45 (5): 635–43. doi:10.1007/s13318-020-00630-8.